ABL Texcell Diagnostics SA (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.380
-0.020 (-0.83%)
Oct 22, 2026, 3:37 PM CEST
ABL Texcell Diagnostics Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 38 | 48 | 40 | 156 | 29 | 4 | |
Market Cap Growth | -47.72% | 21.95% | -74.64% | 439.03% | 627.14% | 34.75% |
Enterprise Value | 39 | 50 | 41 | 158 | 26 | 1 |
Last Close Price | 2.38 | 2.88 | 2.34 | 9.21 | 13.72 | 1.89 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.34 | 48.99 | 139.01 | 2875.26 | 26.23 | 15.47 |
Forward PE | - | 87.50 | 20.50 | - | - | - |
PS Ratio | 3.44 | 6.07 | 6.75 | 25.26 | 3.10 | - |
PB Ratio | 5.39 | 6.33 | 5.30 | 23.10 | 4.29 | 1.52 |
P/TBV Ratio | 7.28 | 7.74 | 5.87 | 25.31 | 4.68 | 1.52 |
P/FCF Ratio | 21.72 | 67.63 | - | - | - | - |
P/OCF Ratio | 14.35 | 32.07 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.52 | 6.29 | 6.99 | 25.49 | 2.83 | - |
EV/EBITDA Ratio | 30.11 | 116.98 | 153.68 | 30731.40 | 42.68 | - |
EV/EBIT Ratio | 26.17 | 158.00 | - | - | 446.41 | - |
EV/FCF Ratio | 22.26 | 70.10 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.26 | 0.30 | 0.34 | 0.51 | 0.39 | 0 |
Debt / EBITDA Ratio | 1.39 | 5.25 | 9.56 | 675.69 | 4.28 | - |
Debt / FCF Ratio | 1.03 | 3.15 | - | - | - | - |
Net Debt / Equity Ratio | 0.14 | 0.12 | 0.27 | 0.18 | 0.24 | -1.03 |
Net Debt / EBITDA Ratio | 0.73 | 2.18 | 7.58 | 242.30 | 2.65 | - |
Net Debt / FCF Ratio | 0.54 | 1.31 | -0.87 | - | - | 47.66 |
Asset Turnover | 0.93 | 0.64 | 0.44 | 0.41 | 1.03 | - |
Inventory Turnover | 5.14 | 6.04 | 6.15 | 7.39 | - | - |
Quick Ratio | 1.30 | 2.32 | 4.37 | 2.33 | 1.89 | 28.79 |
Current Ratio | 1.76 | 2.68 | 4.79 | 2.49 | 2.00 | 28.79 |
Return on Equity (ROE) | 28.20% | 13.05% | 4.00% | 0.80% | 23.59% | 10.36% |
Return on Assets (ROA) | 7.78% | 1.60% | -2.30% | -2.71% | 0.41% | -2.52% |
Return on Invested Capital (ROIC) | 18.59% | 3.51% | -5.60% | -8.01% | 1.43% | - |
Return on Capital Employed (ROCE) | 19.20% | 3.40% | -4.90% | -6.40% | 0.60% | -3.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.17% | 2.04% | 0.72% | 0.03% | 3.81% | 6.47% |
FCF Yield | 4.60% | 1.48% | -5.84% | - | - | -1.42% |
Dividend Yield | 4.62% | 3.66% | 2.03% | - | - | - |
Buyback Yield / Dilution | - | -15.33% | 11.51% | -2.02% | -687.22% | - |
Total Shareholder Return | 4.62% | -11.68% | 13.55% | -2.02% | -687.22% | - |